Gene · 10021
NIH grants1,074
NIH grants whose papers are about the gene, through NIH's grant-paper links.
181 to 200 of 1,074
Download this page as JSON| Grant | Title | HCN4 papers | Newest fiscal year |
|---|---|---|---|
| K08HL152308 | The role of TWIST1 in smooth muscle cells during atherosclerosis | 1 | 2024 |
| K08HL153785 | Elucidation of the Development and Function of the Cardiac Conduction System | 1 | 2024 |
| P30ES000002 | Harvard Chan School NIEHS Center for Environmental Health | 1 | 2024 |
| P30ES030283 | University of Louisville Center for Integrative Environmental Health Sciences | 1 | 2024 |
| P30EY002520 | P30 - Core Grant for Vision Research | 1 | 2024 |
| P42ES017198 | Puerto Rico Testsite for Exploring Contamination Threats (PROTECT) | 1 | 2024 |
| R01DK121072 | Optimization of the engineered 3D hepatic microenvironment enhances pluripotent stem cell derived hepatocyte | 1 | 2024 |
| R01ES031253 | Impact of particle and ozone inhalation co-exposure on alveolar epithelial regeneration | 1 | 2024 |
| R01EY024334 | Targeting the retinoic acid signaling pathway for mitigating visual impairmen in retinal degenerative disorders | 1 | 2024 |
| R01GM124451 | Structural dynamics in cyclic nucleotide-modulated channels | 1 | 2024 |
| R01HL059367 | Epidemiology of Venous Thrombosis and Pulmonary Embolism | 1 | 2024 |
| R01HL127564 | Using genetic variation to study biology of blood lipids & coronary heart disease | 1 | 2024 |
| R01HL128537 | In silico safety pharmacology | 1 | 2024 |
| R01HL146824 | Development of End-To-End Clinical Decision Support Tools To Prevent Cardiotoxic Drug Response | 1 | 2024 |
| R01HL148081 | Metabolic and Transcriptional Reprogramming of Cardiac Maturation | 1 | 2024 |
| R01HL148803 | Personalizing Class I anti-Arrhythmic Drug Therapy | 1 | 2024 |
| R01HL155906 | Gene regulatory networks for heart development | 1 | 2024 |
| R01HL156265 | High-throughput integrated live imaging and optogenetic pacing platform to assess hypoxia responsiveness in the fly heart | 1 | 2024 |
| R01HL156576 | Cardiac Lineage-Specific Molecular Mechanisms of Heart Failure | 1 | 2024 |
| R01HL157363 | Heart rate control with bioengineered pacemakers | 1 | 2024 |
Source NIH's project filesgene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/10021/grants?page=10